Physiological and Metabolic Effects of Grafts in Coronary Artery Bypass Surgery

被引:31
作者
Kitamura, Soichiro [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Osaka 5658565, Japan
关键词
Atherosclerosis; Coronary artery bypass; Endothelium; Internal thoracic artery; Nitric oxide; INTERNAL-MAMMARY-ARTERY; SIROLIMUS-ELUTING STENTS; FRACTIONAL FLOW RESERVE; NITRIC-OXIDE RELEASE; THORACIC-ARTERY; SAPHENOUS-VEIN; RADIAL ARTERY; FOLLOW-UP; FUNCTIONAL SEVERITY; DISEASE PROGRESSION;
D O I
10.1253/circj.CJ-10-1302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The internal thoracic artery (ITA) has become the gold standard graft material for modern coronary artery bypass' grafting (CABG) because of its excellent long-term patency. The use of ITA grafts has also prolonged the post-operative survival of patients when applied to the left anterior descending artery or used bilaterally as 2 grafts for the left coronary system. Moreover, recent large-scale randomized clinical trials comparing the survival rates between CABG and percutaneous coronary intervention (PCI) with stents have shown that CABG is more. effective for improving the survival of patients with severe coronary artery disease and/or in those with diabetes mellitus. The fundamental principle, Underlying thee clinical benefits of CABG is the excellent endothelial function of the ITA. which provides physiological and metabolic effects that are beneficial not only for the graft itself, but also for the recipient coronary system. The production of nitric oxide and prostanoids by the ITA endothelium and their beneficial effects on the downstream coronary artery should therefore be taken into consideration when debating the merits of CABG vs. PCI. (Circ J 2011; 75: 766-772)
引用
收藏
页码:766 / 772
页数:7
相关论文
共 71 条
[1]   Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome [J].
Ahanchi, Sadaf S. ;
Varu, Vinit N. ;
Tsihlis, Nick D. ;
Martinez, Janet ;
Pearce, Charles G. ;
Kapadia, Muneera R. ;
Jiang, Qun ;
Saavedra, Joseph E. ;
Keefer, Larry K. ;
Hrabie, Joseph A. ;
Kibbe, Melina R. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 295 (06) :H2388-H2398
[2]   FLOW CAPACITY OF INTERNAL MAMMARY ARTERY GRAFTS - EARLY RESTRICTION AND LATER IMPROVEMENT ASSESSED BY DOPPLER GUIDE-WIRE - COMPARISON WITH SAPHENOUS-VEIN GRAFTS [J].
AKASAKA, T ;
YOSHIKAWA, J ;
YOSHIDA, K ;
MAEDA, K ;
HOZUMI, T ;
NASU, M ;
SHOMURA, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (03) :640-647
[3]   A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease [J].
Frye R.L. ;
August P. ;
Brooks M.M. ;
Hardison R.M. ;
Kelsey S.F. ;
MacGregor J.M. ;
Orchard T.J. ;
Chaitman B.R. ;
Genuth S.M. ;
Goldberg S.H. ;
Hlatky M.A. ;
Jones T.L.Z. ;
Molitch M.E. ;
Nesto R.W. ;
Sako E.Y. ;
Sobel B.E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (24) :2503-2515
[4]   Remodeling of arterial conduits in coronary grafting [J].
Barner, HB .
ANNALS OF THORACIC SURGERY, 2002, 73 (04) :1341-1345
[5]   Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery [J].
Borges, Jorge Chiquie ;
Lopes, Neuza ;
Soares, Paulo R. ;
Gois, Aecio F. T. ;
Stolf, Noedir A. ;
Oliveira, Sergio A. ;
Hueb, Whady A. ;
Ramires, Jose A. F. .
JOURNAL OF CARDIOTHORACIC SURGERY, 2010, 5
[6]   Coronary bypass surgery with internal-thoracic-artery grafts - Effects on survival over a 15-year period [J].
Cameron, A ;
Davis, KB ;
Green, G ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :216-219
[7]   THE INTERNAL MAMMARY ARTERY MALPERFUSION SYNDROME - INCIDENCE, TREATMENT AND ANGIOGRAPHIC VERIFICATION [J].
CARREL, T ;
KUJAWSKI, T ;
ZUND, G ;
SCHWITTER, J ;
AMANN, FW ;
GALLINO, A ;
BERTEL, O ;
JENNI, R ;
TURINA, M .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1995, 9 (04) :190-197
[8]  
CHAIKHOUNI A, 1986, J THORAC CARDIOV SUR, V92, P88
[9]  
CHENG TO, 1989, ANN THORAC SURG, V48, P747, DOI 10.1016/0003-4975(89)90825-4
[10]  
COSGROVE DM, 1992, ANN THORAC SURG, V53, P159